Human herpesvirus-6 and liver transplantation

Journal of Hepatology

Volumn 37, Issue 5, 2002, Pages 681-683

  Schlitt, Hans J ^a   Shi, Liwei ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW DEPRESSION; BONE MARROW TRANSPLANTATION; CELLULAR IMMUNITY; EDITORIAL; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN HERPESVIRUS 6; IMMUNITY; IMMUNOFLUORESCENCE; INCIDENCE; LATENT VIRUS INFECTION; LIVER TRANSPLANTATION; OPPORTUNISTIC INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROCONVERSION; VIRUS INFECTION; VIRUS REACTIVATION; HUMAN; IMMUNOLOGY; LIVER FAILURE; NOTE; VIROLOGY;

HERPESVIRUS 6, HUMAN; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; ROSEOLOVIRUS INFECTIONS;

EID: 0036847060     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00311-2     Document Type: Editorial

References (33)

1. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986;234:596-601.
2. Okuno T, Takahashi K, Balachandra K, Shiraki K, Yamanishi K, Takahashi M, et al. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol 1989;27:651-653.
3. Krueger GR, Klueppelberg U, Hoffmann A, Ablashi DV. Clinical correlates of infection with human herpesvirus-6. In Vivo 1994;8:457-485.
4. Aubin JT, Collandre H, Candotti D, Ingrand D, Rouxioux C, Burgard M, et al. Several groups among human herpesvirus 6 strains can be distinguished by southern blotting and polymerase chain reaction. J Clin Microbiol 1991;29:367-372.
5. Lautenschlager I, Hockerstedt K, Linnavuori K, Taskinen E. Human herpesvirus-6 infection after liver transplantation. Clin Infect Dis 1998;26:702-707.
6. Yoshikawa T, Ihira M, Furukawa H, Suga S, Asonuma K, Tanaka K, et al. Four cases of human herpesvirus 6 variant B infection after pediatric liver transplantation. Transplantation 1998;65:1266-1269.
7. Singh N, Carrigan DR, Gayowski T, Marino IR. Human herpesvirus-6 infection in liver transplant recipients: Documentation of pathogenicity. Transplantation 1997;64:674-678.
8. Singh N, Carrigan DR, Gayowski T, Singh J, Marino IR, Variant B. Human herpesvirus-6 associated febrile dermatosis with thrombocytopenia and encephalopathy in a liver transplant recipient. Transplantation 1995;60:1355-1357.
9. Schmidt CA, Wilbron F, Weiss K, Brinkmann V, Oettle H, Lohmann R, et al. A prospective study of human herpesvirus type 6 detected by polymerase chain reaction after liver transplantation. Transplantation 1996;61:662-664.
10. Lautenschlager I, Linnavuori K, Hockerstedt K. Human herpesvirus-6 antigenemia after liver transplantation. Transplantation 2000;69:2561-2566.
11. Herbein G, Strasswimmer J, Altieri M, Woehl-Jaegle ML, Wolf P, Obert G. Longitudinal study of human herpesvirus 6 infection in organ transplant recipients. Clin Infect Dis 1996;22:171-173.
12. Yoshikawa T, Ihira M, Suzuki K, Suga S, Iida K, Saito Y, et al. Human herpesvirus 6 infection after living related liver transplantation. J Med Virol 2000;62:52-59.
13. Yoshikawa T, Ihira M, Suzuki K, Suga S, Asano Y, Asonuma K, et al. Primary human herpesvirus 6 infection in liver transplant recipients. J Pediatr 2001;138(6):921-925.
14. Humar A, Kumar D, Caliendo AM, Moussa G, Ashi-Sulaiman A, Levy G, et al. Clinical impact of human herpesvirus 6 infection after liver transplantation. Transplantation 2002;73(4):599-604.
15. Lautenschlager I, Härmä M, Höckerstedt K, Linnavuori K, Loginov R, Taskinen E. Human herpesvirus-6 infection is associated with adhesion molecule induction and lymphocyte infiltration in liver allografts. J Hepatol 2002;37:648-654.
16. + mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. J Immunol 1991;147:685-691.
17. Flamand L, Gosselin J, Stefanescu I, Ablashi D, Menezes J. Immunosuppressive effect of human herpesvirus-6 on T-cell functions: Suppression of interleukin-2 synthesis and cell proliferation. Blood 1995;85:1263-1271.
18. Rogers J, Rohal S, Carrigan DR, Kusne S, Knox KK, Gayowski T, et al. Human herpesvirus-6 in liver transplantation recipients: Role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation 2000;69:2566-2573.
19. Stoeckle MY. The spectrum of human herpesvirus 6 infection: From roseola infantum to adult disease. Annu Rev Med 2000;51:423-430.
20. Ihira M, Yoshikawa T, Suzuki K, Ohashi M, Suga S, Asonuma K, et al. Correlation between human herpesvirus 6 and 7 infections after living related liver transplantation. Microbiol Immunol 2001;45:225-232.
21. Appleton AL, Sviland L, Peiris JS, Taylor CE, Wilkes J, Green MA, et al. Human herpes virus-6 infection in marrow graft recipients: Role in pathogenesis of graft-versus-host disease. Bone Marrow Transplant 1995;16:777-782.
22. Burd EM, Carrigan DR. Human herpesvirus 6 (HHV-6)-associated dysfunction of blood monocytes. Virus Res 1993;29:79-90.
23. Flamand L, Gosselin J, D'Addario M, Hiscott J, Ablashi DV, Gallo RC. et al. Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral mononuclear cell cultures. J Virol 1991;65:5105-5110.
24. Griffiths PD, Ait-Khaled M, Bearcroft CP, Clark DA, Quaglia A, Davies SE, et al. Human herpesviruses 6 and 7 as potential pathogens after liver transplant: Prospective comparison with the effect of cytomegalovirus. J Med Virol 1999;59:496-501.
25. Dockrell DH, Prada J, Jones MF, Patel R, Badley AD, Harmsen WS, et al. Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease. J Infect Dis 1997;176:1135-1140.
26. DesJardin JA, Cho E, Supran S, Gibbons L, Werner BG, Snydman DR. Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated diseases in orthotopic liver transplant recipients. Clin Infect Dis 2001;33:1358-1362.
27. Singh N, Husain S, Carrigan DR, Knox KK, Weck KE, Wagener MM, et al. Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients. Clin Transplant 2002;16:92-96.
28. Burns WH, Sandford GR. Susceptibility of human herpesvirus 6 to antivirals in vitro. J Infect Dis 1990;162:634-637.
29. Manichanh C, Grenot P, Gautheret-Dejean A, Debre P, Huraux JM, Agut H. Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis. Cytometry 2000;40:135-140.
30. De Clercq E, Naesens L, De Bolle L, Schols D, Zhang Y, Neyts J. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. Rev Med Virol 2001;11:381-395.
31. Drobyski WR, Dunne WM, Burd EM, Knox KK, Ash RC, Horowitz MM, et al. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: Evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis 1993;167:735-739.
32. Bethge W, Beck R, Jahn G, Mundinger P, Kanz L, Einsele H. Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation. Bone Marrow Transplant 1999;24:1245-1248.
33. Lowance D, Neumayer HH, Legendre CM, Squifflet JP, Kovarik J. Brennan PJ, et al. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N Engl J Med 1999;340:1462-1470.